Cargando…

Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction

Background: Programmed death-ligand 1 (PD-L1) is expressed not only on some cancer cells, but also on the outer surface of placental syncytiotrophoblasts, which is assumed to induce maternal immune tolerance to fetal tissue via programmed death-1 (PD-1) receptors on T cells. Recently, levels of solu...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuyama, Mai, Mezawa, Hidetoshi, Kawai, Toshinao, Urashima, Mitsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387906/
https://www.ncbi.nlm.nih.gov/pubmed/30833943
http://dx.doi.org/10.3389/fimmu.2019.00086
_version_ 1783397658806714368
author Okuyama, Mai
Mezawa, Hidetoshi
Kawai, Toshinao
Urashima, Mitsuyoshi
author_facet Okuyama, Mai
Mezawa, Hidetoshi
Kawai, Toshinao
Urashima, Mitsuyoshi
author_sort Okuyama, Mai
collection PubMed
description Background: Programmed death-ligand 1 (PD-L1) is expressed not only on some cancer cells, but also on the outer surface of placental syncytiotrophoblasts, which is assumed to induce maternal immune tolerance to fetal tissue via programmed death-1 (PD-1) receptors on T cells. Recently, levels of soluble forms of PD-L1 (sPD-L1) were reported to be higher in the serum of pregnant women (PW) than in non-pregnant women (non-PW). However, there have been no reports of the functional significance of PW's serum containing high sPD-L1 levels. Therefore, the aim of the present study was to clarify the role of sPD-L1 in the sera of PW as an immunosuppressive molecule by in vitro assays. Methods: As a post-hoc analysis of our previous cohort study, 330 pairs of serum from PW during the third trimester and cord blood (CB) from paired offspring without major complications were examined. Serum levels of sPD-L1 and sPD-1 were measured by ELISA. On mixed lymphocyte culture (MLC), (3)H-thymidine uptakes in the presence of PW's, offspring's, or non-PW's serum were compared. Peripheral blood mononuclear cells (PBMCs) were cultured in the presence of PW's serum stimulated with PHA, and then cytokine levels were measured in supernatants by multiple cytokine analysis with or without anti-PD-L1blocking antibody. Results: The median sPD-L1 level was 8.3- and 6.9-fold higher in PW than in offspring and non-PW, respectively, whereas sPD-1 levels were lower in PW and offspring than in non-PW. On MLC, (3)H-thymidine uptake in the presence of autoantigen was strongly reduced by co-culture with serum of both PW and offspring, compared with serum of non-PW. In contrast, uptake in the presence of alloantigen was moderately inhibited by PW's serum, whereas it was less suppressed by offspring's serum, compared with non-PW's serum. In the culture of PBMCs, tumor necrosis factor-α, interferon gamma, interleukin (IL)-2, and IL-4 levels were significantly higher in the presence of anti-PD-L1 blocking antibody than in culture not treated with antibody (all P < 0.05) or culture treated with isotype control antibody (all P < 0.05). Conclusion: The levels of sPD-L1 are elevated in PW's serum, which may, at least in part, suppress maternal immunity.
format Online
Article
Text
id pubmed-6387906
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63879062019-03-04 Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction Okuyama, Mai Mezawa, Hidetoshi Kawai, Toshinao Urashima, Mitsuyoshi Front Immunol Immunology Background: Programmed death-ligand 1 (PD-L1) is expressed not only on some cancer cells, but also on the outer surface of placental syncytiotrophoblasts, which is assumed to induce maternal immune tolerance to fetal tissue via programmed death-1 (PD-1) receptors on T cells. Recently, levels of soluble forms of PD-L1 (sPD-L1) were reported to be higher in the serum of pregnant women (PW) than in non-pregnant women (non-PW). However, there have been no reports of the functional significance of PW's serum containing high sPD-L1 levels. Therefore, the aim of the present study was to clarify the role of sPD-L1 in the sera of PW as an immunosuppressive molecule by in vitro assays. Methods: As a post-hoc analysis of our previous cohort study, 330 pairs of serum from PW during the third trimester and cord blood (CB) from paired offspring without major complications were examined. Serum levels of sPD-L1 and sPD-1 were measured by ELISA. On mixed lymphocyte culture (MLC), (3)H-thymidine uptakes in the presence of PW's, offspring's, or non-PW's serum were compared. Peripheral blood mononuclear cells (PBMCs) were cultured in the presence of PW's serum stimulated with PHA, and then cytokine levels were measured in supernatants by multiple cytokine analysis with or without anti-PD-L1blocking antibody. Results: The median sPD-L1 level was 8.3- and 6.9-fold higher in PW than in offspring and non-PW, respectively, whereas sPD-1 levels were lower in PW and offspring than in non-PW. On MLC, (3)H-thymidine uptake in the presence of autoantigen was strongly reduced by co-culture with serum of both PW and offspring, compared with serum of non-PW. In contrast, uptake in the presence of alloantigen was moderately inhibited by PW's serum, whereas it was less suppressed by offspring's serum, compared with non-PW's serum. In the culture of PBMCs, tumor necrosis factor-α, interferon gamma, interleukin (IL)-2, and IL-4 levels were significantly higher in the presence of anti-PD-L1 blocking antibody than in culture not treated with antibody (all P < 0.05) or culture treated with isotype control antibody (all P < 0.05). Conclusion: The levels of sPD-L1 are elevated in PW's serum, which may, at least in part, suppress maternal immunity. Frontiers Media S.A. 2019-02-18 /pmc/articles/PMC6387906/ /pubmed/30833943 http://dx.doi.org/10.3389/fimmu.2019.00086 Text en Copyright © 2019 Okuyama, Mezawa, Kawai and Urashima. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Okuyama, Mai
Mezawa, Hidetoshi
Kawai, Toshinao
Urashima, Mitsuyoshi
Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction
title Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction
title_full Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction
title_fullStr Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction
title_full_unstemmed Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction
title_short Elevated Soluble PD-L1 in Pregnant Women's Serum Suppresses the Immune Reaction
title_sort elevated soluble pd-l1 in pregnant women's serum suppresses the immune reaction
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387906/
https://www.ncbi.nlm.nih.gov/pubmed/30833943
http://dx.doi.org/10.3389/fimmu.2019.00086
work_keys_str_mv AT okuyamamai elevatedsolublepdl1inpregnantwomensserumsuppressestheimmunereaction
AT mezawahidetoshi elevatedsolublepdl1inpregnantwomensserumsuppressestheimmunereaction
AT kawaitoshinao elevatedsolublepdl1inpregnantwomensserumsuppressestheimmunereaction
AT urashimamitsuyoshi elevatedsolublepdl1inpregnantwomensserumsuppressestheimmunereaction